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Improvement in HOMA-IR is an independent predictor
of reduced carotid intima-media thickness in obese
adolescents participating in an interdisciplinary
weight-loss program
Priscila de Lima Sanches1, Marco Tu´lio de Mello1,2,3, Nata´lia Elias3, Francisco Antonio Helfenstein Fonseca4,
Aline de Piano1, June Carnier1, Lila Missae Oyama1,5, Lian Tock1, Sergio Tufik2,3 and Ana Raimunda Daˆmaso1,6
The aim of this study was to verify whether a 1-year interdisciplinary weight-loss program improved common carotid artery
intima-media thickness (IMT) and whether insulin resistance and/or inflammation (as measured by the markers plasminogen
activator inhibitor type-1 and adiponectin) might underlie obesity in adolescents. A group of 29 post-pubescent obese
adolescents were submitted to an interdisciplinary intervention over the course of 1 year. Common carotid artery IMT was
determined ultrasonographically. Body composition, blood pressure (BP), glycemia, insulinemia, homeostasis model assessment
of insulin resistance (HOMA-IR), lipid profile and adipokine concentrations were analyzed before and after the intervention.
The interdisciplinary weight-loss program promoted a significant improvement in body composition, insulin concentration,
HOMA-IR, lipid profile, BP and inflammatory state, in addition to significantly decreasing the common carotid artery IMT.
Furthermore, this study demonstrated that the difference between baseline and final values of HOMA-IR (DHOMA-IR) was
negatively correlated with concomitant changes in the adiponectin concentration (Dadiponectin; r¼0.42; P¼0.02) and
positively correlated with changes in common carotid artery IMT (Dcarotid IMT; r¼0.41; P¼0.03). Multiple regression analysis
adjusted by age, cardiovascular risk factors and inflammatory markers showed that DHOMA-IR was an independent predictor of
significant changes in common carotid artery IMT. This investigation demonstrated that an interdisciplinary weight-loss program
promoted a reduction of the common carotid artery IMT in obese Brazilian adolescents, and the improvement of HOMA-IR was
an independent predictor of carotid IMT changes in this population.
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INTRODUCTION
The prevalence of childhood obesity in Brazil has almost tripled over
the past 30 years, and B23% of Latin American children and
adolescents are overweight.1,2 The relationship between obesity in
childhood and adolescence, and the development of hemodynamic,
thrombotic and inflammatory disorders, such as atherosclerosis, later
in life is well supported in the literature.3
Atherosclerosis can begin in relatively young individuals and con-
tinue to develop for many decades before clinical signs are observed or
cardiovascular events occur. The first subclinical sign of atherosclerosis
is an increase in arterial intima-media thickness (IMT), the result
of endothelial dysfunction that leaves lipid deposits in the intima
of systemic arteries.4 Many hypotheses link obesity, endothelial
dysfunction and subclinical signs of atherosclerosis in obese subjects.
The majority of research shows that the increase in IMT in obese
individuals is influenced by plasma lipid concentration, hyper-
tension, inflammatory state, physical inactivity and impaired glucose
metabolism.5–7
Among these precursors, insulin resistance seems to be a strong risk
factor for the development of atherosclerosis. The negative correlation
between insulin resistance and adiponectin may serve as a link between
obesity and atherosclerosis. Adiponectin is an anti-inflammatory
adipokine that has an insulin-like role in promoting vasodilatation
and anti-atherosclerotic effects, stimulating nitric oxide production
in endothelial cells and inhibiting the release of proinflammatory
adipokines, which in turn contribute to a coupling of vascular insulin
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resistance and endothelial dysfunction.8,9 Moreover, a decrease in
insulin sensitivity is related to increases in the endothelial expression
of plasminogen activator inhibitor type-1 (PAI-1) and cellular/vascular
adhesion molecules implicated in the initiation of endothelial
dysfunction.4,9,10
The prevalence of cardiovascular diseases in children and adoles-
cents is increasing, and there is evidence that carotid IMT is higher in
children with diabetes, hypercholesterolemia and obesity than in
healthy controls.4,5,6,11 Some studies of the effects of exercise training,
either associated with dietary changes or alone, showed that weight
loss and physical exercise decrease insulin resistance and improve
endothelial dysfunction in adults.12,13 However, few studies have
investigated the effects of 1 year of interdisciplinary intervention in
this parameter in obese adolescents.14,15
The aim of this investigation was to verify whether 1 year of an
interdisciplinary weight-loss program improved common carotid
artery IMT and whether insulin resistance and/or inflammation
(as measured by the levels of markers, plasminogen activator inhibitor
type-1 and adiponectin) might underlie obesity in Brazilian
adolescents.
METHODS
Study subjects
A total of 29 post-pubescent16 obese adolescents (body mass index
(BMI)495th percentile on the Centers for Disease Control and Prevention
(CDC) reference growth charts),17 aged from 14 to 19 years (16.03±1.59
years), including 17 girls and 12 boys, were recruited for an interdisciplinary
weight-loss program that lasted for 1 year. The inclusion criteria for the post-
pubertal stage were based on the Tanner scale (stage five) for both boys and
girls. Non-inclusion criteria were as follows: other metabolic or endocrine
diseases; chronic alcohol consumption; previous use of drugs, such as anabolic-
androgenic steroids or psychotropics, which may affect appetite regulation; and
pregnancy. Informed parental consent and the adolescents’ assent to participate
as volunteers in an interdisciplinary weight-loss program were obtained. This
study was conducted in accordance with the principles of the Helsinki
Declaration and was formally approved by the ethics committee of the Federal
University of Sa˜o Paulo (number: 0135/04).
Anthropometric measurements and body composition
Subjects were weighed while wearing light clothing and no shoes on a Filizola
scale to the nearest 0.1 kg. Height was measured to the nearest 0.5 cm with a
wall-mounted stadiometer (Sanny, Sa˜o Bernardo do Campo, SP, Brazil; model
ES 2030). BMI was calculated as body weight divided by height squared
(weight/height2). Body composition was measured by plethysmography in a
BOD POD body composition system (version 1.69; Life Measurement Instru-
ments, Concord, CA, USA).
Measurements of visceral and subcutaneous fat
All abdominal ultrasonography procedures and measurements of visceral and
subcutaneous fat were performed by the same blinded diagnostic imaging
specialist using a 3.5MHz multifrequency transducer (broadband). This
procedure allowed a reduction in the risk margin for misclassification. The
intra-examination coefficient of variation for ultrasonography was 0.8%.
Ultrasonography measurements of intra-abdominal (visceral) and subcuta-
neous fat were taken. Ultrasonography-determined subcutaneous fat was
defined as the distance between the skin and external face of the rectus
abdominis muscle, and visceral fat was defined as the distance between the
internal face of the same muscle and the anterior wall of the aorta.18
Measurements of carotid artery IMT
Carotid artery IMTwas measured using high-resolution ultrasound equipment
(logic 5 and logic 7, General Electric, Sa˜o Paulo, SP, Brazil) with a 7–14MHz
linear array transducer. Measurements were taken by the same experienced
radiologist, who performed all scans and was unaware of the medical and
biochemical status of the subject. The intra-examination coefficient of variation
for IMT was 4.36%. Patients were examined in the supine position with the
neck in hyperextension. The protocol involved repeated measurements of the
right and left common carotid far wall at 2 cm proximal to the bulb bifurcation.
On a longitudinal B-mode image, the far wall of the common carotid
artery appears as two bright, parallel lines separated by a hypoechoic space.
The distance between the leading edge of the first bright line on the far wall
(lumen–intima interface) and the leading edge of the second bright line
(media–adventitia interface) indicates the IMT of the far wall, as previously
described.19 Three measurements of the left and right common carotid were
taken, and the mean for the higher measures of each side, representing the IMT,
was used11 for statistical analysis.
Serum analysis
Blood samples were collected at the outpatient clinic atB0800 hours after an
overnight fast. After collection, the blood was centrifuged for 10min at
5000 r.p.m. and stored at 70 1C for future analyses. The materials used for
collection were disposable, adequately labeled and of recognized quality. Blood
was collected by a skilled and qualified technician.
Insulin resistance can be defined as decreased sensitivity or responsiveness to
the metabolic actions of insulin.10 The homeostasis model assessment of insulin
resistance index (HOMA-IR) seems to be the index with the highest sensitivity
and specificity for measuring insulin sensitivity and was the one selected for use
in this study. The cutoff point adopted for adolescents was 3.16.20 HOMA-IR
was calculated as the product of blood glucose (fasting blood glucose) and
immunoreactive insulin (I): (fasting blood glucose (mg per 100ml)I
(mU l1)/405). The coefficient of variation for the insulin test was 3.3%.
Dyslipidemia is a lipid metabolic alteration arising from disturbances in any
lipid metabolism phase that alter serum concentrations of lipoprotein. To
identify any individuals with abnormal lipid profiles, we used the reference
values from the I Guideline for Preventing Atherosclerosis in Childhood and
Adolescence.21 All variables were analyzed using a commercial kit (CELM,
Barueri, Brazil).
The levels of adiponectin and PAI-1 were measured using a commercially
available enzyme-linked immunosorbent assay kit from R&D Systems
(Minneapolis, MN, USA), according to the instructions of the manufacturer.
The coefficients of variation for the adiponectin and PAI-1 procedure were
5.18 and 4.5%, respectively.
Blood pressure (BP)
BP was measured on the right arm using a mercury-gravity manometer with
proper cuff size, with the volunteers in the seated position. The first appearance
of sound (phase 1 Korotkoff sound) was used to define systolic BP, and the
disappearance of sound (phase 5 Korotkoff sound) was used to define diastolic
BP.1 Hypertension was determined by reference values of BP percentiles for
gender, according to age and height percentile.21
Research design
The interdisciplinary weight-loss program combined exercise training (aerobic
plus resistance training) with clinical, nutritional and psychological therapy. The
use of this kind of therapy has been suggested by the World Health Organiza-
tion.22 All measurements were performed before and after 1 year of intervention.
Exercise protocol. The combined exercise training program was conducted
three times per week for 1 year, and included 30min of aerobic training plus
30min of resistance training per session. The subjects were instructed to reverse
the order of the exercises (aerobic and resistance) at each training session. The
aerobic training consisted of running on a motor-driven treadmill (Life Fitness,
Schiller Park, IL, USA, Model TR 9700HR) at a cardiac frequency intensity
representing ventilatory threshold I (±4 b.p.m.), as determined by the results
of an initial oxygen uptake test for aerobic exercises. The exercise program was
based on guidelines from the American College of Sports Medicine.23
Resistance training was also designed based on American College of Sports
Medicine recommendations.24 Exercises targeted each of the main muscle
groups. After an introductory period, the load of training was adjusted such
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that volume and intensity were adjusted inversely, decreasing the number of
repetitions to between 6 and 20 repetitions, for three sets.
All sessions were supervised individually by an experienced physiologist.
Psychological therapy. Psychological therapy treatment plans were established
on the basis of validated questionnaires that considered some of the psycho-
logical problems caused by obesity, as described in the literature. These include
depression, eating disorders, anxiety, decreased self-esteem and body image
disorders. Interdisciplinary therapy consisted of a weekly 1-h group session.
Individualized psychological therapy was recommended when weight problems
were found.
Nutritional therapy. Energy intake was set at levels recommended for subjects
with low levels of physical activity of the same age and gender following a
balanced diet. Once a week, adolescents received nutrition lessons covering the
topics related to a healthy eating pattern. All patients received individual
nutritional consultation during the intervention program. At the beginning of
the study and at 12 months into the program, a 3-day dietary record was
collected. Because most obese people under report their food consumption,
each adolescent was asked to record their diet with help from his or her parents.
The degree of under reporting may still be substantial; however, this is a
validated method for the assessment of dietary consumption.25 These dietary
data were transferred to a computer by the same dietician, and the nutrient
composition was analyzed by a PC program developed at the Federal University
of Sa˜o Paulo–Paulista Medicine School (Nutwin software, for Windows,
version 1.5, 2002).
Clinical therapy. To address the health and clinical parameters, obese adoles-
cents visited the endocrinologist once each month. Medical follow-up and
treatment were based on an initial patient and family history, physical
examination and intervention in any health problems that had developed over
the course of the therapy.
Statistical analysis
Statistical analyses were performed using STATISTICA (Tulsa, OK, USA;
version 7.0 for Windows). The Gaussian distribution of variables (including
D values) was verified with a Shapiro–Wilk’s W-test. Variables with normal
distribution were expressed as mean±s.d., whereas variables without normal
distribution were expressed as median (quartile range) in a descriptive table.
Non-parametric methods were used when appropriate (for BMI, visceral and
subcutaneous fat, triglyceride levels, systolic and diastolic BP, carotid IMT, PAI-
1 and adiponectin concentration). Comparisons between measurements before
and after intervention were performed with paired Student’s t-tests for
parametric variables and Wilcoxon’s signed rank test for non-parametric
variables. Pearson’s correlation coefficients were calculated to assess possible
relationships between normally distributed variables. Multiple regression ana-
lysis was used to verify the influence of changes in the traditional cardiovascular
risk factors and adipokine concentrations on carotid IMT changes.
RESULTS
The clinical characteristics of the 29 subjects who completed the
therapy with participation in475% of treatment sessions are shown
in Table 1. The results are presented for the whole population studied,
because we did not find significant gender differences in carotid IMT.
Significant reductions were observed in total body mass, BMI, fat
body mass (% and kg), visceral and subcutaneous fat, systolic and
diastolic BP, insulin concentration, HOMA-IR, total cholesterol and
low-density lipoprotein-cholesterol. In addition, 1 year of interdisci-
plinary intervention promotes a significant increase in lean body mass
(% and kg) and high-density lipoprotein-cholesterol. The PAI-1
concentration and common carotid IMT were significantly reduced
(D¼3.90; Pp0.01; D¼0.06, Pp0.01, respectively), whereas adi-
ponectin concentration was increased (D¼2.12, Pp0.01; Figure 1).
According to nutritional profile data, the obese adolescents had
significantly reduced their total energy intake, macronutrients
(in grams) and lipid percentage by the end of the intervention
(Table 2).
After analyzing the correlation between DHOMA-IR with lipid profile
(Dtriglycerides, Dhigh-density lipoprotein-cholesterol, Dlow-density lipo-
protein-cholesterol and Dtotal cholesterol), inflammatory factors (DPAI-1
and Dadiponectin), Dsystolic BP and Ddiastolic BP, a negative correla-
tion was found only between DHOMA-IR and changes in adiponectin
concentration (Dadiponectin; r¼0.42, P¼0.02; Figure 2a). Meanwhile,
a positive correlation was observed between DHOMA-IR and changes
in carotid IMT (DIMT; r¼0.41, P¼0.03; Figure 2b).
Table 1 Clinical characteristic at baseline and after interdisciplinary intervention
Baseline n¼29 (17 female; 12 male) After 1 year n¼29 (17 female; 12 male) D P-value
Age 16.03±1.59 —
Total body mass (kg) 102.31±13.35 88.96±11.24 13.35±6.95 p0.01
BMI (kg m2) 35.19 (33.13–38.85) 31.19 (27.78–33.45) 5.17±2.45 p0.01
Fat body mass (%) 46.10±5.79 35.94±7.74 10.16±4.44 p0.01
Lean body mass (%) 53.90±5.79 64.06±7.74 10.16±4.44 p0.01
Fat body mass (kg) 47.52±10.44 32.42±9.80 15.11±6.09 p0.01
Lean body mass (kg) 54.79±6.59 56.56±6.87 1.78±3.15 p0.01
Waist circumference (cm) 103.58±9.79 89.84±10.23 16.84±18.65 p0.01
Visceral fat (cm) 3.80 (3.10–4.50) 2.19 (1.80–2.90) 1.59±0.99 p0.01
Subcutaneous fat (cm) 3.60 (3.40–4.30) 3.20 (2.60–3.50) 1.00±0.82 p0.01
SBP (mm Hg) 120 (110–130) 110 (110–120) 9.66±16.74 p0.01
DBP (mmHg) 80 (75–85) 70 (70–80) 6.14±7.13 p0.01
Total cholesterol (mg per 100 ml) 172.17±33.30 155.38±30.81 16.79±21.69 p0.01
LDL-c (mg per 100 ml) 108.90±29.29 94.55±25.81 14.34±17.18 p0.01
HDL-c(mg per 100 ml) 42.69±7.12 45.00±8.02 2.31±5.88 p0.01
Triglycerides (mg per 100 ml) 102.00 (68.00–112.00) 73.00 (62.00–79.00) 23.97±37.75 p0.01
Glucose (mg per 100 ml) 88.97±7.02 87.72±7.76 1.24±10.63 0.85
Insulin (mU ml1) 16.18±4.61 8.93±3.71 7.24±4.34 p0.01
HOMA-IR 3.57±1.13 1.97±0.92 1.69±1.21 p0.01
Abbreviations: BMI, body mass index; DBP, diastolic blood pressure; HDL-c, high-density lipoprotein-cholesterol; HOMA-IR, homeostasis model assessment insulin resistance index; LDL-c, low-
density lipoprotein-cholesterol; SBP, systolic blood pressure.
Data expressed as mean±s.d. or median (quartile range).
Reference values20: total cholesterolo150; LDL-co100; HDL-cX45; triglycerideso100.
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Multiple regression analysis adjusted by age, traditional cardiovas-
cular risk factors and inflammatory markers revealed DHOMA-IR to
be an independent predictor of significant reduction in carotid IMT
(b¼0.03, P¼0.02; Table 3).
It is also extremely important to emphasize that this interdisciplinary
intervention reduced the prevalence of insulin resistance (from 66 to
17%), dyslipidemia (from 17 to 10%) and hypertension (from 41 to 0%).
DISCUSSION
Considerable effort has been spent understanding the biology under-
lying the development of cardiovascular disease and identifying its risk
factors.26 Several subclinical pathological conditions may be present
during adolescence and can evolve over time, suggesting that further
investigations will be required to investigate the primary prevention
and early diagnosis of chronic diseases during this period.3
During recent years, our group has been dedicated to developing
interdisciplinary interventions that aim to control obesity and its
comorbidities, such as non-alcoholic fatty liver disease,25 metabolic
syndrome1 and, now, atherosclerosis.
Recent research showed that 1 h of isolated aerobic training three
times a week for 6 months was able to promote a reduction in body
weight, BP, insulin resistance and carotid IMT in obese adolescents
(BMI¼29.8 kgm2±5.9; age between 11 and 16 years).27 Another
study demonstrated that a 6month regimen of diet alone or diet plus
exercise training decreased carotid IMT in overweight children
(BMI¼25kgm2±3; age between 9 and 12 years).14 In this study,
1 year of intervention promoted a significant decrease in carotid IMT
in obese adolescents (BMI¼36.50 kgm2±4.99; age between 14 and
19 years). The most relevant guidelines in the field of cardiovascular
disease prevention strongly emphasize the need for overweight
and obese individuals to change their lifestyles in order to
reduce body weight and thereby improve BP and lower cardiovascular
disease risk.28
To better explore the factors that precipitated the carotid IMT
reduction in this study, multiple regression analysis was performed.
It was found that change in HOMA-IR was an independent predictor
of improvement in carotid IMT. A literature review by Reaven
supports this hypothesis, strongly suggesting that insulin resistance
is a physiological state associated with an increased risk of developing
a cluster of abnormalities and clinical symptoms commonly observed
in cardiometabolic syndrome.29
The influence of insulin resistance on the vasculature can occur
directly and indirectly. Because insulin is a major stimulus for nitric
oxide-mediated vasodilation, insulin resistance could contribute to
impaired nitric oxide-mediated vasodilation, leading to endothelial
dysfunction. Furthermore, insulin resistance also contributes to
impaired lipid metabolism and activation of inflammatory signaling
in the vasculature. However, the indirect mechanism may require a
longer time to manifest,30 which could explain the lack of association
between the changes in HOMA-IR and changes in lipid profiles and
PAI-1, in this study.
Perhaps the most crucial idea suggested by this investigation is that
the indirect influence of individual metabolic syndrome parameters
on the risk of cardiovascular disease, including carotid IMT, may be
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Figure 1 Values of Adiponectin concentration (a), PAI-1 concentration (b)
and common carotid IMT (c) before and after interdisciplinary intervention
(n¼29; *Pp0.01).
Table 2 Energy and macronutrients intake at baseline and after
interdisciplinary intervention
Nutrients Baseline After 1 year
Energy intake (kcal) 1900.85±586 1331.25±444.42#
Carbohydrate (g) 232.80±87.57 177.90±51.62#
Carbohydrate (%) 50.50±6.72 56.90±14.61
Protein (g) 89.38±24.65 63.54±24.35#
Protein (%) 19.27±4.16 19.29±4.69
Lipid (g) 66.59±27.26 39.09±19.36#
Lipid (%) 31.03±4.96 25.69±7.28#
#Pp0.05.
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mediated through insulin resistance. However, this should be con-
firmed in a large cohort study. This finding would be not only
biologically important but also clinically significant, as it would
allow insulin resistance to become the main focus in the prevention
of atherosclerosis in obese adolescents.
When we analyzed the nutritional profile of the study popula-
tion, it was observed that 1 year of interdisciplinary therapy
promoted a significant reduction in total energy intake, macro-
nutrients (in grams) and lipid percentage, reinforcing the impor-
tance of nutritional counseling in obesity treatment as well as in
cardiovascular disease prevention. This finding is in line with
results reported by Semenkovich,31 which suggested that the
delivery of excess fuel may cause mitochondrial stress, which can
lead to increased production of reactive oxygen species, further
contributing to endothelial dysfunction and the inflammatory
state. Therefore, this study recommends reducing fat intake and
increasing physical activity as strategies to minimize the impact of
obesity on inflammatory disorders.27 A similar interdisciplinary
intervention should be considered as a potential therapeutic
strategy.
Our intervention was also able to promote a significant increase
in serum adiponectin concentration (Pp0.01), which probably
contributed to the improvement in insulin resistance and decrease
in carotid IMT. Previous studies have demonstrated that this
adipokine stimulates potent anti-inflammatory and atheroprotective
responses in vascular tissue, in addition to its insulin-sensitizing effects
in tissues involved in glucose and lipid metabolism.7,9
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Figure 2 Correlations of DHOMA-IR with Dadiponectin (a) and Dcommon carotid IMT (b) in obese adolescents. (a) n¼29; r¼0.42; P¼0.02. (b) n¼29;
r¼0.41; P¼0.03.
Table 3 Multiple regression analysis for the determinants of changes
in common carotid IMT
D Common carotid IMT
Regression coefficient b P
Age 0.01 0.19
DLDL-c (mg per 100 ml) 0.00 0.62
DSBP (mm Hg) 0.00 0.69
DDBP (mmHg) 0.00 0.50
DVisceral fat (cm) 0.02 0.22
DHOMA-IR 0.03 0.02
DPAI-1 (ng ml1) 0.00 1.00
Abbreviations: DBP, diastolic blood pressure; HOMA-IR, homeostasis model assessment insulin
resistance index; IMT, intima-media thickness; LDL-c, low-density lipoprotein-cholesterol; PAI-1,
plasminogen activator inhibitor type-1; SBP, systolic blood pressure.
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Thus, the reduced circulating concentration of adiponectin
observed in obese subjects could contribute not only to insulin
resistance but also to endothelial vascular dysfunction. Adiponectin
may be more closely related to atherosclerosis in obese children than
are conventional cardiovascular risk factors and inflammation status.6
For example, it has been demonstrated that high adiponectin con-
centration can suppress the development of atherosclerosis in suscep-
tible mice.32 Consistent with this hypothesis, our study verified a
negative correlation between change in HOMA-IR and change in
adiponectin concentration.
Additionally, insulin resistance and inflammation may promote an
altered profile of vascular function and, consequently, hypertension.
Insulin resistance increases the endothelial expression of PAI-1 and
cellular adhesion molecules,33,34 suggesting that multiple mechanisms
may contribute to accelerated atherosclerosis.7,35 Thus, the decrease in
PAI-1 concentration observed in this investigation may help to
attenuate the monocyte migratory capacity mediated by insulin in a
pro-inflammatory and atherothrombotic state. This mechanism
should be investigated more fully.
The small sample size used in this study can be considered as a
limitation of our study. Nevertheless, for the first time, we showed that
a change in HOMA-IR was an independent predictor for change in
carotid IMT among obese Brazilian adolescents. Another finding of
great value in this investigation was a negative correlation between
change in HOMA-IR and changes in adiponectin concentration.
Beauloye et al.6 showed a negative correlation between adiponectin
and carotid IMT in children and adolescents, but only at baseline
conditions. These results reinforce the importance of adopting strate-
gies that promote an improvement of HOMA-IR and adiponectine-
mia, which could influence IMT measurements.
It is of utmost relevance that the IMT change is multifactorial36
and, in this age group, may be strongly influenced by fatty acid and
inflammatory infiltration, despite the improvement in other variables
considered to cause the reduction in carotid artery IMT.
Although some of our patients remained obese at the end of
therapy, the changes in lifestyle (mostly increased physical activity
and decreased food intake) promoted by this type of intervention can
be considered essential to create a better metabolic profile and thereby
reduce atherosclerotic risk. Moreover, these results showed that these
patients require intensive and long-term therapy. Furthermore, study
recruitment and compliance with any treatment is more difficult in
adolescent populations, and the success of treatment depends at least
partly on the participation of parents and/or guardians.37
In conclusion, this shows that obesity intervention may prevent the
development of cardiovascular disease among adolescents.
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